Karen Pomeranz

Karen Pomeranz is a Strategy Consultant at Putnam, a role she has held since December 2021. In her current position, she focuses on strategic initiatives within the pharmaceutical sector. Prior to joining Putnam, she worked as a Senior Manager in Research & Development at Evaluate Ltd from April 2021 to April 2022, and before that, she served as a Managing Analyst in Product Development at the same company for over four years. Her earlier experience includes a position as a Senior Business Insights Analyst in oncology at Decision Resources Group from January 2011 to January 2017.

Pomeranz holds a PhD in Molecular Medicine from Imperial College London, where her research focused on the regulation of FoxO transcription factors in breast cancer. She is proficient in both English and Hebrew, reflecting her diverse linguistic capabilities.1